title: The therapeutic efficacy of rosiglitazone is enhanced in sulphonylurea-treated patients with type 2 diabetes.
authors.forename: H
authors.initials: H
authors.lastname: Itakura
authors.forename: F
authors.initials: F
authors.lastname: Abbasi
authors.forename: C
authors.initials: C
authors.lastname: Lamendola
authors.forename: M
authors.initials: M
authors.lastname: Basina
authors.forename: G
authors.initials: G
authors.lastname: Reaven
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D000077154:Rosiglitazone; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D000077154:Rosiglitazone